相关实验视频

Updated: May 23, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

探索免疫检查点抑制剂:专注于PD-1/PD-L1轴及其他轴

Durre Aden¹, Samreen Zaheer², Niti Sureka³

¹Department of Pathology, Hamdard Institute of Medical science and research, Jamia Hamdard, New Delhi, India.

Pathology, research and practice

|March 11, 2025

概括

免疫检查点抑制剂,如那些向编程细胞死亡蛋白1 (PD-1) 和其连接体 (PD-L1) 的免疫检查点抑制剂,通过增强免疫系统对抗瘤的能力,正在彻底改变癌症免疫疗法. 本综述探讨了它们的机制,应用和未来方向.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

免疫疗法取得了重大进展,揭示了免疫系统在瘤发育和治疗反应中的作用.
免疫检查点抑制剂 (ICI) 利用免疫系统向癌细胞,PD-1/PD-L1抑制剂显示出显著的疗效.
了解这些相互作用对于改善癌症治疗策略至关重要.

研究的目的:

审查癌症免疫治疗中PD-1/PD-L1阻断的作用机制,临床用途和新策略.
检查PD-1/PD-L1和其他免疫检查点之间的相互作用,用于组合疗法.
讨论针对CTLA-4,LAG-3,TIM-3和TIGIT的新兴ICI.

主要方法:

关于PD-1/PD-L1阻断的临床前和临床研究的全面分析.
关于免疫检查点相互作用和新型治疗点的文献综述.
综合有关ICI有效性和挑战的当前知识.

主要成果:

PD-1/PD-L1 抑制剂在各种癌症中显示出显著的临床疗效.
组合方法和新的ICI目标在克服阻力方面显示出希望.
该领域正在迅速发展,正在研究新的治疗策略.

结论:

阻断PD-1/PD-L1代表了癌症免疫疗法的重大进展.
进一步研究组合疗法和新目标对于优化治疗结果至关重要.
免疫检查点封锁对未来的癌症治疗创新有很大的希望.

关键词:

免疫检查点抑制剂免疫检查点抑制剂免疫治疗是一种免疫疗法.在PD-1中使用PD-1.在PD-L1中.

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...